Three-Step Cell Enrichment in Less than 20 Minutes
The LeviCell™ Provides a Gentle, Efficient, and Simple Solution to Dead Cell and Debris Removal.
Introduction
In cellular biology, downstream assay results are highly dependent on the quality of the preliminary samples used. Poor quality samples – such as those containing a high percentage of dead cells and debris – will produce poor results. It is the fundamental quality of the starting sample that ultimately dictates the quality of the results, and it is the sample preparation step which is often the most difficult to achieve successfully.
By utilizing the LeviCellTM platform for cell isolation, scientists have consistently demonstrated robust enrichment for a wide range of target cells – without affecting cellular expression or original population representation. This innovative levitation technology has clinical implications and applications that span a range of diseases and therapies.
Traditional methods used to separate specific cell types from a mixed population include magnetic beads, gradient purification, and flow cytometry. Although these techniques are widely used, they are not necessarily the most efficient or effective way to enrich for a target cell population.
Common issues that haunt scientists who use these methods include introducing artificial stress on cells that inevitably lead to an alteration in their expression profile (Van Den Brink et al., 2017), antibody-induced intracellular signaling (Kornbluth and Hoover, 1989; Christaki et al., 2011), as well as osmotic- and pressure-induced changes to the cell expression profile of multiple cell types (Xiong et al., 2002; Romero-santacreu et al., 2009; Van Den Brink et al., 2017).
These issues are not taken lightly, as they come at a price: the expenses associated with garnering difficult-to-obtain samples, materials, and labor; the immeasurable cost of frustration; and the irreplaceable expense of time. To this end, the LeviCellTM is a game changer.
Methods
Levitas Bio has developed an innovative levitation technology platform that uses less than 1 psi of pressure to enable a completely touch-free, label-free, three-step sorting process that takes only 20 minutes to complete.
Live cell populations levitate much higher than dead cells and debris, allowing for clear separation and collection by the LeviCell™, as shown. Please note that the fluorescent dyes used in the provided image were used solely to highlight the separation process and are not required to use the LeviCell™.
The gentle separation process used by the LeviCell™ maintains maximum cell viability, enabling the preservation of cell population representation integrity for downstream assays such as single-cell analysis. The simple three-step process streamlines the workflow and minimizes the risk of contamination and damage from multiple instances of handling and washing, consequently maximizing enrichment for each cell type.
STEP 1
Sample Introduction
Sample pipetted into the LeviCell™ cartridge.
STEP 2
Automated Label-Free Sorting
Precision density gradients drive levitation based on cells physical properties.
STEP 3
Sample Collection
Selected populations collected into separate ports for further analysis or use.
Results
Primary samples were processed on the LeviCell™ and using the most common bead-based approach from a leading supplier. The results presented here for both methods were achieved by manually counting the live and dead cells to calculate the yields and viabilities.
Revolutionary viability and yields
The LeviCell™ demonstrated the successful removal of dead cells and debris from a variety of primary samples while maintaining the original representation of the populations found within the sample. Furthermore, the LeviCell™ was able to enrich a low starting number of live cells to a viability of >90%, exhibiting a capacity for scalability regardless of starting number of cells. 100,000 cells from each of two Dissociated Tumor Cells (DTC) were processed on the LeviCellTM. Both samples were successfully processed and enriched to 90% viable cells, by removing dead cells and debris in just 3 simple steps and < 20 min.
Viability vs. Cancer & Fraction
Superior LeviCellTM performance over bead based methods
The ovarian sample was split into two fractions of 100,000 cells and each fraction independently processed on the LeviCellTM and using a popular bead-based dead cell removal kit. The output from each enrichment method was then analyzed by manually counting the cells using a Trypan Blue stain and a hemocytometer. The LeviCellTM clearly outperforms the standard bead method in both Yield and Viability, while providing a faster, simpler and much more accommodating workflow when working with difficult samples. Furthermore, as demonstrated in the section below, the LeviCellTM maintains the original cellular representation of the native sample without affecting the gene expression profile or activation state in even the most sensitive cell types.
Viability vs. Sort Method & Sort
Yield vs. Sort Method
Maximum levitation height difference between differentiated and undifferentiated adipocytes was achieved using 30 mM of Levitation Agent (Figure a above). Note that as the concentration of Levitation Agent increased, overall levitation height of both populations increased while the distance between differentiated and undifferentiated cells decreased
No negative effects on post-processing population representation
The data on the right show how the LeviCellTM’s gentle cell separation approach enables the study of notoriously delicate and sensitive primary cell types without compromising the integrity of the original cell populations. Sorted and unsorted ovarian DTC samples were blocked with TruStain human Fc Block for 15 minutes at RT then stained with 5 μL each of anti-CD45, anti-CD19, anti-CD11b, and 10 μL of anti-CD3, for 30 minutes at room temperature. Samples were washed with FACS buffer (0.5% BSA in PBS) once before analyzing on a Sony SH800S cytometer. The LeviCellTM output shows a similar amount of CD3+, CD19+, and CD11b+ cells within the CD45+ lymphocyte population while the sample processed by the bead method shows reduced proportions of CD3+ and CD11b+ cells.
No effect on the post-processing activation state
Maximum levitation height Macrophages, one of most sensitive cell types, were used in order to demonstrate the gentleness of the LeviCellTM. Data exhibited below clearly show that the LeviCellTM has no negative side effects on the post-processing activation state of cells.
RAW264.7 cells were treated with IFN-g and IL-4 in order to polarize the macrophages into either the M1 or M2 stage. The samples were then processed on the LeviCellTM system. qRT-PCR was than performed to examine the expression of M1 specific gene (iNOS) or M2 specific (Arg1) in these cells to show that their activation states were not altered by the LeviCellTM. No differences in gene expression were observed between the input and output cells for the activation states.
Conclusion
The LeviCellTM’s unique levitation platform enables scientists to significantly reduce costs (financial and otherwise) by reducing the amount of time to enrich for specific cell types from hours and days to mere minutes. The three-step process simplifies the workflow and minimizes the need for highly skilled technicians and complicated single-cell preparation protocols. Because the LeviCellTM does not use any high pressure, labels, dyes, or antibodies to isolate cells, alteration of expression profile is a needless worry. The LeviCellTM’s closed environment also eliminates the risk of contamination and cell death due to manual manipulation. Separating live cells from dead and debris is as easy as finding the line of delineation between them.
